Bio-Techne
TECH
#1993
Rank
A$14.45 B
Marketcap
A$92.75
Share price
-2.93%
Change (1 day)
-22.98%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): A$0.79

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is A$0.75. In 2024 the company made an earnings per share (EPS) of A$1.50 a decrease over its 2023 EPS that were of A$2.14.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.79-47.53%
2024A$1.50-29.58%
2023A$2.14-14.97%
2022A$2.5124.16%
2021A$2.0217.98%
2020A$1.71-10.94%
2019A$1.92101.57%
2018A$0.95-16.99%
2017A$1.1545.02%
2016A$0.79-20.97%
2015A$1.00-14.97%
2014A$1.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$26.07 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A-$36.55-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$8.38 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$7.34 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$2.81 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
A$11.37 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A-$0.32-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA